In vivo phenotypic screening: clinical proof of concept for a drug repositioning approach
Author:
Publisher
Elsevier BV
Subject
Drug Discovery,Molecular Medicine
Reference35 articles.
1. Lessons learned from the fate of AstraZeneca’s drug pipeline: a five-dimensional framework;Cook;Nat Rev Drug Discov,2014
2. Novel phenotypic outcomes identified for a public collection of approved drugs from a publicly accessible panel of assays;Lee;PLoS One,2015
3. Lessons from 60 years of pharmaceutical innovation;Munos;Nat Rev Drug Discov,2009
4. How were new medicines discovered?;Swinney;Nat Rev Drug Discov,2011
5. An analysis of the attrition of drug candidates from four major pharmaceutical companies;Waring;Nat Rev Drug Discov,2015
Cited by 15 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Repurposing approved non-oncology drugs for cancer therapy: a comprehensive review of mechanisms, efficacy, and clinical prospects;European Journal of Medical Research;2023-09-14
2. Repurposing Drugs: A New Paradigm and Hopes for Life-threatening Diseases;Drug Repurposing Against SARS-CoV-2;2023-04-12
3. A New Approach to Drug Repurposing with Two-Stage Prediction, Machine Learning, and Unsupervised Clustering of Gene Expression;OMICS: A Journal of Integrative Biology;2022-06-01
4. Phenotypic drug discovery: recent successes, lessons learned and new directions;Nature Reviews Drug Discovery;2022-05-30
5. Polypharmacology in Old Drug Rediscovery: Drug Repurposing;Polypharmacology;2022
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3